Table: Rohto - 9-MTH group results

Rohto Pharmaceutical

09/02/2024 06:00

Feb 9 (Reuters)- 
             Rohto Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Dec 31, 2023        Dec 31, 2022     Mar 31, 2024 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales              201.16              176.26           272.00    
                   (+14.1 pct)         (+22.4 pct)      (+14.0 pct) 
  Operating           35.26               28.60            40.00    
                   (+23.3 pct)         (+22.5 pct)      (+17.8 pct) 
  Recurring           37.25               29.54            41.50    
                   (+26.1 pct)         (+25.5 pct)      (+16.7 pct) 
  Net                 26.16               21.64            30.00    
                   (+20.9 pct)         (+26.5 pct)      (+13.7 pct) 
  EPS              114.66 yen           94.84 yen       131.50 yen  
  EPS Diluted      114.33 yen           94.57 yen                   
  Ann Div                                                27.00 yen  
  -Q2 div           12.00 yen           20.00 yen                   
  -Q4 div                               12.00 yen        15.00 yen  
  
  NOTE - Rohto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T